Global Immune Globulin Intravenous Market Research Report 2020


The global Immune Globulin Intravenous market is valued at US$ xx million in 2020 is expected to reach US$ xx million by the end of 2026, growing at a CAGR of xx% during 2021-2026.
This report focuses on Immune Globulin Intravenous volume and value at the global level, regional level and company level. From a global perspective, this report represents overall Immune Globulin Intravenous market size by analysing historical data and future prospect. Regionally, this report focuses on several key regions: North America, Europe, China and Japan etc.
Market Segment Analysis
The research report includes specific segments by Type and by Application. This study provides information about the sales and revenue during the historic and forecasted period of 2015 to 2026. Understanding the segments helps in identifying the importance of different factors that aid the market growth.
Segment by Type, the Immune Globulin Intravenous market is segmented into
    IVIg Liquid
    IVIg Powder

Segment by Application
    Immunodeficiency
    Autoimmune Disease
    Acute Infection

 Global Immune Globulin Intravenous Market: Regional Analysis
The Immune Globulin Intravenous market is analysed and market size information is provided by regions (countries). The report includes country-wise and region-wise market size for the period 2015-2026. It also includes market size and forecast by Type and by Application segment in terms of sales and revenue for the period 2015-2026.
The key regions covered in the Immune Globulin Intravenous market report are:
North America
    U.S.
    Canada
Europe
    Germany
    France
    U.K.
    Italy
    Russia
Asia-Pacific
    China
    Japan
    South Korea
    India
    Australia
    Taiwan
    Indonesia
    Thailand
    Malaysia
    Philippines
    Vietnam
Latin America
    Mexico
    Brazil
    Argentina
Middle East & Africa
    Turkey
    Saudi Arabia
    U.A.E
Global Immune Globulin Intravenous Market: Competitive Analysis
This section of the report identifies various key manufacturers of the market. It helps the reader understand the strategies and collaborations that players are focusing on combat competition in the market. The comprehensive report provides a significant microscopic look at the market. The reader can identify the footprints of the manufacturers by knowing about the global revenue of manufacturers, the global price of manufacturers, and sales by manufacturers during the forecast period of 2015 to 2019.
The major players in global Immune Globulin Intravenous market include:
    Baxter
    Grifols
    CSL
    Octapharma
    Biotest
    Kedrion
    Hualan Bio
    CNBG
    Shanghai RAAS
    CBPO
    LFB Group
    BPL
    Sichuan Yuanda Shuyang
Table of Contents

1 Immune Globulin Intravenous Market Overview
    1.1 Product Overview and Scope of Immune Globulin Intravenous
    1.2 Immune Globulin Intravenous Segment by Type
        1.2.1 Global Immune Globulin Intravenous Sales Growth Rate Comparison by Type (2021-2026)
        1.2.2 IVIg Liquid
        1.2.3 IVIg Powder
    1.3 Immune Globulin Intravenous Segment by Application
        1.3.1 Immune Globulin Intravenous Sales Comparison by Application: 2020 VS 2026
        1.3.2 Immunodeficiency
        1.3.3 Autoimmune Disease
        1.3.4 Acute Infection
    1.4 Global Immune Globulin Intravenous Market Size Estimates and Forecasts
        1.4.1 Global Immune Globulin Intravenous Revenue 2015-2026
        1.4.2 Global Immune Globulin Intravenous Sales 2015-2026
        1.4.3 Immune Globulin Intravenous Market Size by Region: 2020 Versus 2026

2 Global Immune Globulin Intravenous Market Competition by Manufacturers
    2.1 Global Immune Globulin Intravenous Sales Market Share by Manufacturers (2015-2020)
    2.2 Global Immune Globulin Intravenous Revenue Share by Manufacturers (2015-2020)
    2.3 Global Immune Globulin Intravenous Average Price by Manufacturers (2015-2020)
    2.4 Manufacturers Immune Globulin Intravenous Manufacturing Sites, Area Served, Product Type
    2.5 Immune Globulin Intravenous Market Competitive Situation and Trends
        2.5.1 Immune Globulin Intravenous Market Concentration Rate
        2.5.2 Global Top 5 and Top 10 Players Market Share by Revenue
        2.5.3 Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
    2.6 Manufacturers Mergers & Acquisitions, Expansion Plans
    2.7 Primary Interviews with Key Immune Globulin Intravenous Players (Opinion Leaders)

3 Immune Globulin Intravenous Retrospective Market Scenario by Region
    3.1 Global Immune Globulin Intravenous Retrospective Market Scenario in Sales by Region: 2015-2020
    3.2 Global Immune Globulin Intravenous Retrospective Market Scenario in Revenue by Region: 2015-2020
    3.3 North America Immune Globulin Intravenous Market Facts & Figures by Country
        3.3.1 North America Immune Globulin Intravenous Sales by Country
        3.3.2 North America Immune Globulin Intravenous Sales by Country
        3.3.3 U.S.
        3.3.4 Canada
    3.4 Europe Immune Globulin Intravenous Market Facts & Figures by Country
        3.4.1 Europe Immune Globulin Intravenous Sales by Country
        3.4.2 Europe Immune Globulin Intravenous Sales by Country
        3.4.3 Germany
        3.4.4 France
        3.4.5 U.K.
        3.4.6 Italy
        3.4.7 Russia
    3.5 Asia Pacific Immune Globulin Intravenous Market Facts & Figures by Region
        3.5.1 Asia Pacific Immune Globulin Intravenous Sales by Region
        3.5.2 Asia Pacific Immune Globulin Intravenous Sales by Region
        3.5.3 China
        3.5.4 Japan
        3.5.5 South Korea
        3.5.6 India
        3.5.7 Australia
        3.5.8 Taiwan
        3.5.9 Indonesia
        3.5.10 Thailand
        3.5.11 Malaysia
        3.5.12 Philippines
        3.5.13 Vietnam
    3.6 Latin America Immune Globulin Intravenous Market Facts & Figures by Country
        3.6.1 Latin America Immune Globulin Intravenous Sales by Country
        3.6.2 Latin America Immune Globulin Intravenous Sales by Country
        3.6.3 Mexico
        3.6.3 Brazil
        3.6.3 Argentina
    3.7 Middle East and Africa Immune Globulin Intravenous Market Facts & Figures by Country
        3.7.1 Middle East and Africa Immune Globulin Intravenous Sales by Country
        3.7.2 Middle East and Africa Immune Globulin Intravenous Sales by Country
        3.7.3 Turkey
        3.7.4 Saudi Arabia
        3.7.5 U.A.E
4 Global Immune Globulin Intravenous Historic Market Analysis by Type
    4.1 Global Immune Globulin Intravenous Sales Market Share by Type (2015-2020)
    4.2 Global Immune Globulin Intravenous Revenue Market Share by Type (2015-2020)
    4.3 Global Immune Globulin Intravenous Price Market Share by Type (2015-2020)
    4.4 Global Immune Globulin Intravenous Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End

5 Global Immune Globulin Intravenous Historic Market Analysis by Application
    5.1 Global Immune Globulin Intravenous Sales Market Share by Application (2015-2020)
    5.2 Global Immune Globulin Intravenous Revenue Market Share by Application (2015-2020)
    5.3 Global Immune Globulin Intravenous Price by Application (2015-2020)

6 Company Profiles and Key Figures in Immune Globulin Intravenous Business
    6.1 Baxter
        6.1.1 Corporation Information
        6.1.2 Baxter Description, Business Overview and Total Revenue
        6.1.3 Baxter Immune Globulin Intravenous Sales, Revenue and Gross Margin (2015-2020)
        6.1.4 Baxter Products Offered
        6.1.5 Baxter Recent Development
    6.2 Grifols
        6.2.1 Grifols Immune Globulin Intravenous Production Sites and Area Served
        6.2.2 Grifols Description, Business Overview and Total Revenue
        6.2.3 Grifols Immune Globulin Intravenous Sales, Revenue and Gross Margin (2015-2020)
        6.2.4 Grifols Products Offered
        6.2.5 Grifols Recent Development
    6.3 CSL
        6.3.1 CSL Immune Globulin Intravenous Production Sites and Area Served
        6.3.2 CSL Description, Business Overview and Total Revenue
        6.3.3 CSL Immune Globulin Intravenous Sales, Revenue and Gross Margin (2015-2020)
        6.3.4 CSL Products Offered
        6.3.5 CSL Recent Development
    6.4 Octapharma
        6.4.1 Octapharma Immune Globulin Intravenous Production Sites and Area Served
        6.4.2 Octapharma Description, Business Overview and Total Revenue
        6.4.3 Octapharma Immune Globulin Intravenous Sales, Revenue and Gross Margin (2015-2020)
        6.4.4 Octapharma Products Offered
        6.4.5 Octapharma Recent Development
    6.5 Biotest
        6.5.1 Biotest Immune Globulin Intravenous Production Sites and Area Served
        6.5.2 Biotest Description, Business Overview and Total Revenue
        6.5.3 Biotest Immune Globulin Intravenous Sales, Revenue and Gross Margin (2015-2020)
        6.5.4 Biotest Products Offered
        6.5.5 Biotest Recent Development
    6.6 Kedrion
        6.6.1 Kedrion Immune Globulin Intravenous Production Sites and Area Served
        6.6.2 Kedrion Description, Business Overview and Total Revenue
        6.6.3 Kedrion Immune Globulin Intravenous Sales, Revenue and Gross Margin (2015-2020)
        6.6.4 Kedrion Products Offered
        6.6.5 Kedrion Recent Development
    6.7 Hualan Bio
        6.6.1 Hualan Bio Immune Globulin Intravenous Production Sites and Area Served
        6.6.2 Hualan Bio Description, Business Overview and Total Revenue
        6.6.3 Hualan Bio Immune Globulin Intravenous Sales, Revenue and Gross Margin (2015-2020)
        6.4.4 Hualan Bio Products Offered
        6.7.5 Hualan Bio Recent Development
    6.8 CNBG
        6.8.1 CNBG Immune Globulin Intravenous Production Sites and Area Served
        6.8.2 CNBG Description, Business Overview and Total Revenue
        6.8.3 CNBG Immune Globulin Intravenous Sales, Revenue and Gross Margin (2015-2020)
        6.8.4 CNBG Products Offered
        6.8.5 CNBG Recent Development
    6.9 Shanghai RAAS
        6.9.1 Shanghai RAAS Immune Globulin Intravenous Production Sites and Area Served
        6.9.2 Shanghai RAAS Description, Business Overview and Total Revenue
        6.9.3 Shanghai RAAS Immune Globulin Intravenous Sales, Revenue and Gross Margin (2015-2020)
        6.9.4 Shanghai RAAS Products Offered
        6.9.5 Shanghai RAAS Recent Development
    6.10 CBPO
        6.10.1 CBPO Immune Globulin Intravenous Production Sites and Area Served
        6.10.2 CBPO Description, Business Overview and Total Revenue
        6.10.3 CBPO Immune Globulin Intravenous Sales, Revenue and Gross Margin (2015-2020)
        6.10.4 CBPO Products Offered
        6.10.5 CBPO Recent Development
    6.11 LFB Group
        6.11.1 LFB Group Immune Globulin Intravenous Production Sites and Area Served
        6.11.2 LFB Group Immune Globulin Intravenous Description, Business Overview and Total Revenue
        6.11.3 LFB Group Immune Globulin Intravenous Sales, Revenue and Gross Margin (2015-2020)
        6.11.4 LFB Group Products Offered
        6.11.5 LFB Group Recent Development
    6.12 BPL
        6.12.1 BPL Immune Globulin Intravenous Production Sites and Area Served
        6.12.2 BPL Immune Globulin Intravenous Description, Business Overview and Total Revenue
        6.12.3 BPL Immune Globulin Intravenous Sales, Revenue and Gross Margin (2015-2020)
        6.12.4 BPL Products Offered
        6.12.5 BPL Recent Development
    6.13 Sichuan Yuanda Shuyang
        6.13.1 Sichuan Yuanda Shuyang Immune Globulin Intravenous Production Sites and Area Served
        6.13.2 Sichuan Yuanda Shuyang Immune Globulin Intravenous Description, Business Overview and Total Revenue
        6.13.3 Sichuan Yuanda Shuyang Immune Globulin Intravenous Sales, Revenue and Gross Margin (2015-2020)
        6.13.4 Sichuan Yuanda Shuyang Products Offered
        6.13.5 Sichuan Yuanda Shuyang Recent Development

7 Immune Globulin Intravenous Manufacturing Cost Analysis
    7.1 Immune Globulin Intravenous Key Raw Materials Analysis
       7.1.1 Key Raw Materials
       7.1.2 Key Raw Materials Price Trend
       7.1.3 Key Suppliers of Raw Materials
    7.2 Proportion of Manufacturing Cost Structure
    7.3 Manufacturing Process Analysis of Immune Globulin Intravenous
    7.4 Immune Globulin Intravenous Industrial Chain Analysis

8 Marketing Channel, Distributors and Customers
    8.1 Marketing Channel
    8.2 Immune Globulin Intravenous Distributors List
    8.3 Immune Globulin Intravenous Customers

9 Market Dynamics
    9.1 Market Trends
    9.2 Opportunities and Drivers
    9.3 Challenges
    9.4 Porter's Five Forces Analysis

10 Global Market Forecast
    10.1 Global Immune Globulin Intravenous Market Estimates and Projections by Type
        10.1.1 Global Forecasted Sales of Immune Globulin Intravenous by Type (2021-2026)
        10.1.2 Global Forecasted Revenue of Immune Globulin Intravenous by Type (2021-2026)
    10.2 Immune Globulin Intravenous Market Estimates and Projections by Application
        10.2.1 Global Forecasted Sales of Immune Globulin Intravenous by Application (2021-2026)
        10.2.2 Global Forecasted Revenue of Immune Globulin Intravenous by Application (2021-2026)
    10.3 Immune Globulin Intravenous Market Estimates and Projections by Region
        10.3.1 Global Forecasted Sales of Immune Globulin Intravenous by Region (2021-2026)
        10.3.2 Global Forecasted Revenue of Immune Globulin Intravenous by Region (2021-2026)
    10.4 North America Immune Globulin Intravenous Estimates and Projections (2021-2026)
    10.5 Europe Immune Globulin Intravenous Estimates and Projections (2021-2026)
    10.6 Asia Pacific Immune Globulin Intravenous Estimates and Projections (2021-2026)
    10.7 Latin America Immune Globulin Intravenous Estimates and Projections (2021-2026)
    10.8 Middle East and Africa Immune Globulin Intravenous Estimates and Projections (2021-2026)
11 Research Finding and Conclusion

12 Methodology and Data Source
    12.1 Methodology/Research Approach
        12.1.1 Research Programs/Design
        12.1.2 Market Size Estimation
        12.1.3 Market Breakdown and Data Triangulation
    12.2 Data Source
        12.2.1 Secondary Sources
        12.2.2 Primary Sources
    12.3 Author List
    12.4 Disclaimer

List of Tables Table 1. Global Immune Globulin Intravenous Sales (MT) Growth Rate Comparison by Type (2015-2026) Table 2. Global Immune Globulin Intravenous Sales (MT) Comparison by Application: 2020 VS 2026 Table 3. Global Immune Globulin Intravenous Market Size by Type (MT) (US$ Million) (2020 VS 2026) Table 4. Global Key Immune Globulin Intravenous Manufacturers Covered in This Study Table 5. Global Immune Globulin Intravenous Sales (MT) by Manufacturers (2015-2020) Table 6. Global Immune Globulin Intravenous Sales Share by Manufacturers (2015-2020) Table 7. Global Immune Globulin Intravenous Revenue (Million USD) by Manufacturers (2015-2020) Table 8. Global Immune Globulin Intravenous Revenue Share by Manufacturers (2015-2020) Table 9. Global Market Immune Globulin Intravenous Average Price (USD/Kg) of Key Manufacturers (2015-2020) Table 10. Manufacturers Immune Globulin Intravenous Sales Sites and Area Served Table 11. Manufacturers Immune Globulin Intravenous Product Types Table 12. Global Immune Globulin Intravenous Manufacturers Market Concentration Ratio (CR5 and HHI) Table 13. Global Immune Globulin Intravenous by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Immune Globulin Intravenous as of 2019) Table 14. Manufacturers Mergers & Acquisitions, Expansion Plans Table 15. Main Points Interviewed from Key Immune Globulin Intravenous Players Table 16. Global Immune Globulin Intravenous Sales (MT) by Region (2015-2020) Table 17. Global Immune Globulin Intravenous Sales Market Share by Region (2015-2020) Table 18. Global Immune Globulin Intravenous Revenue (Million US$) by Region (2015-2020) Table 19. Global Immune Globulin Intravenous Revenue Market Share by Region (2015-2020) Table 20. North America Immune Globulin Intravenous Sales by Country (2015-2020) (MT) Table 21. North America Immune Globulin Intravenous Sales Market Share by Country (2015-2020) Table 22. North America Immune Globulin Intravenous Revenue by Country (2015-2020) (US$ Million) Table 23. North America Immune Globulin Intravenous Revenue Market Share by Country (2015-2020) Table 24. Europe Immune Globulin Intravenous Sales by Country (2015-2020) (MT) Table 25. Europe Immune Globulin Intravenous Sales Market Share by Country (2015-2020) Table 26. Europe Immune Globulin Intravenous Revenue by Country (2015-2020) (US$ Million) Table 27. Europe Immune Globulin Intravenous Revenue Market Share by Country (2015-2020) Table 28. Asia Pacific Immune Globulin Intravenous Sales by Region (2015-2020) (MT) Table 29. Asia Pacific Immune Globulin Intravenous Sales Market Share by Region (2015-2020) Table 30. Asia Pacific Immune Globulin Intravenous Revenue by Region (2015-2020) (US$ Million) Table 31. Asia Pacific Immune Globulin Intravenous Revenue Market Share by Region (2015-2020) Table 32. Latin America Immune Globulin Intravenous Sales by Country (2015-2020) (MT) Table 33. Latin America Immune Globulin Intravenous Sales Market Share by Country (2015-2020) Table 34. Latin America Immune Globulin Intravenous Revenue by Country (2015-2020) (US$ Million) Table 35. Latin America Immune Globulin Intravenous Revenue Market Share by Country (2015-2020) Table 36. Middle East and Africa Immune Globulin Intravenous Sales by Country (2015-2020) (MT) Table 37. Middle East and Africa Immune Globulin Intravenous Sales Market Share by Country (2015-2020) Table 38. Middle East and Africa Immune Globulin Intravenous Revenue by Country (2015-2020) (US$ Million) Table 39. Middle East and Africa Immune Globulin Intravenous Revenue Market Share by Country (2015-2020) Table 40. Global Immune Globulin Intravenous Sales (MT) by Type (2015-2020) Table 41. Global Immune Globulin Intravenous Sales Share by Type (2015-2020) Table 42. Global Immune Globulin Intravenous Revenue (Million US$) by Type (2015-2020) Table 43. Global Immune Globulin Intravenous Revenue Share by Type (2015-2020) Table 44. Global Immune Globulin Intravenous Price (USD/Kg) by Type (2015-2020) Table 45. Global Immune Globulin Intravenous Sales (MT) by Application (2015-2020) Table 46. Global Immune Globulin Intravenous Sales Market Share by Application (2015-2020) Table 47. Global Immune Globulin Intravenous Sales Growth Rate by Application (2015-2020) Table 48. Baxter Immune Globulin Intravenous Corporation Information Table 49. Baxter Description and Business Overview Table 50. Baxter Immune Globulin Intravenous Sales (MT), Revenue (Million US$), Price (USD/Kg) and Gross Margin (2015-2020) Table 51. Baxter Main Product Table 52. Baxter Recent Development Table 53. Grifols Immune Globulin Intravenous Corporation Information Table 54. Grifols Corporation Information Table 55. Grifols Immune Globulin Intravenous Sales (MT), Revenue (Million US$), Price (USD/Kg) and Gross Margin (2015-2020) Table 56. Grifols Main Product Table 57. Grifols Recent Development Table 58. CSL Immune Globulin Intravenous Corporation Information Table 59. CSL Corporation Information Table 60. CSL Immune Globulin Intravenous Sales (MT), Revenue (Million US$), Price (USD/Kg) and Gross Margin (2015-2020) Table 61. CSL Main Product Table 62. CSL Recent Development Table 63. Octapharma Immune Globulin Intravenous Corporation Information Table 64. Octapharma Corporation Information Table 65. Octapharma Immune Globulin Intravenous Sales (MT), Revenue (Million US$), Price (USD/Kg) and Gross Margin (2015-2020) Table 66. Octapharma Main Product Table 67. Octapharma Recent Development Table 68. Biotest Immune Globulin Intravenous Corporation Information Table 69. Biotest Corporation Information Table 70. Biotest Immune Globulin Intravenous Sales (MT), Revenue (Million US$), Price (USD/Kg) and Gross Margin (2015-2020) Table 71. Biotest Main Product Table 72. Biotest Recent Development Table 73. Kedrion Immune Globulin Intravenous Corporation Information Table 74. Kedrion Corporation Information Table 75. Kedrion Immune Globulin Intravenous Sales (MT), Revenue (Million US$), Price (USD/Kg) and Gross Margin (2015-2020) Table 76. Kedrion Main Product Table 77. Kedrion Recent Development Table 78. Hualan Bio Immune Globulin Intravenous Corporation Information Table 79. Hualan Bio Corporation Information Table 80. Hualan Bio Immune Globulin Intravenous Sales (MT), Revenue (Million US$), Price (USD/Kg) and Gross Margin (2015-2020) Table 81. Hualan Bio Main Product Table 82. Hualan Bio Recent Development Table 83. CNBG Immune Globulin Intravenous Corporation Information Table 84. CNBG Corporation Information Table 85. CNBG Immune Globulin Intravenous Sales (MT), Revenue (Million US$), Price (USD/Kg) and Gross Margin (2015-2020) Table 86. CNBG Main Product Table 87. CNBG Recent Development Table 88. Shanghai RAAS Immune Globulin Intravenous Corporation Information Table 89. Shanghai RAAS Corporation Information Table 90. Shanghai RAAS Immune Globulin Intravenous Sales (MT), Revenue (Million US$), Price (USD/Kg) and Gross Margin (2015-2020) Table 91. Shanghai RAAS Main Product Table 92. Shanghai RAAS Recent Development Table 93. CBPO Immune Globulin Intravenous Corporation Information Table 94. CBPO Corporation Information Table 95. CBPO Immune Globulin Intravenous Sales (MT), Revenue (Million US$), Price (USD/Kg) and Gross Margin (2015-2020) Table 96. CBPO Main Product Table 97. CBPO Recent Development Table 98. LFB Group Immune Globulin Intravenous Corporation Information Table 99. LFB Group Corporation Information Table 100. LFB Group Immune Globulin Intravenous Sales (MT), Revenue (Million US$), Price (USD/Kg) and Gross Margin (2015-2020) Table 101. LFB Group Main Product Table 102. LFB Group Recent Development Table 103. BPL Immune Globulin Intravenous Corporation Information Table 104. BPL Corporation Information Table 105. BPL Immune Globulin Intravenous Sales (MT), Revenue (Million US$), Price (USD/Kg) and Gross Margin (2015-2020) Table 106. BPL Main Product Table 107. BPL Recent Development Table 108. Sichuan Yuanda Shuyang Immune Globulin Intravenous Corporation Information Table 109. Sichuan Yuanda Shuyang Corporation Information Table 110. Sichuan Yuanda Shuyang Immune Globulin Intravenous Sales (MT), Revenue (Million US$), Price (USD/Kg) and Gross Margin (2015-2020) Table 111. Sichuan Yuanda Shuyang Main Product Table 112. Sichuan Yuanda Shuyang Recent Development Table 113. Sales Base and Market Concentration Rate of Raw Material Table 114. Key Suppliers of Raw Materials Table 115. Immune Globulin Intravenous Distributors List Table 116. Immune Globulin Intravenous Customers List Table 117. Market Key Trends Table 118. Key Opportunities and Drivers: Impact Analysis (2021-2026) Table 119. Key Challenges Table 120. Global Immune Globulin Intravenous Sales (MT) Forecast by Type (2021-2026) Table 121. Global Immune Globulin Intravenous Sales Market Share Forecast by Type (2021-2026) Table 122. Global Immune Globulin Intravenous Revenue (Million US$) Forecast by Type (2021-2026) Table 123. Global Immune Globulin Intravenous Revenue (Million US$) Market Share Forecast by Type (2021-2026) Table 124. Global Immune Globulin Intravenous Sales (MT) Forecast by Application (2021-2026) Table 125. Global Immune Globulin Intravenous Revenue (Million US$) Forecast by Application (2021-2026) Table 126. Global Immune Globulin Intravenous Sales (MT) Forecast by Region (2021-2026) Table 127. Global Immune Globulin Intravenous Sales Market Share Forecast by Region (2021-2026) Table 128. Global Immune Globulin Intravenous Revenue Forecast by Region (2021-2026) (US$ Million) Table 129. Global Immune Globulin Intravenous Revenue Market Share Forecast by Region (2021-2026) Table 130. Research Programs/Design for This Report Table 131. Key Data Information from Secondary Sources Table 132. Key Data Information from Primary Sources List of Figures Figure 1. Picture of Immune Globulin Intravenous Figure 2. Global Immune Globulin Intravenous Sales Market Share by Type: 2020 VS 2026 Figure 3. IVIg Liquid Product Picture Figure 4. IVIg Powder Product Picture Figure 5. Global Immune Globulin Intravenous Consumption Market Share by Application: 2020 VS 2026 Figure 6. Immunodeficiency Figure 7. Autoimmune Disease Figure 8. Acute Infection Figure 9. Global Immune Globulin Intravenous Market Size 2015-2026 (US$ Million) Figure 10. Global Immune Globulin Intravenous Sales Capacity (MT) (2015-2026) Figure 11. Global Immune Globulin Intravenous Market Size Market Share by Region: 2020 Versus 2026 Figure 12. Immune Globulin Intravenous Sales Share by Manufacturers in 2020 Figure 13. Global Immune Globulin Intravenous Revenue Share by Manufacturers in 2019 Figure 14. The Global 5 and 10 Largest Players: Market Share by Immune Globulin Intravenous Revenue in 2019 Figure 15. Immune Globulin Intravenous Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019 Figure 16. Global Immune Globulin Intravenous Sales Market Share by Region (2015-2020) Figure 17. Global Immune Globulin Intravenous Sales Market Share by Region in 2019 Figure 18. Global Immune Globulin Intravenous Revenue Market Share by Region (2015-2020) Figure 19. Global Immune Globulin Intravenous Revenue Market Share by Region in 2019 Figure 20. North America Immune Globulin Intravenous Sales Market Share by Country in 2019 Figure 21. North America Immune Globulin Intravenous Revenue Market Share by Country in 2019 Figure 22. U.S. Immune Globulin Intravenous Sales Growth Rate (2015-2020) (MT) Figure 23. U.S. Immune Globulin Intravenous Revenue Growth Rate (2015-2020) (US$ Million) Figure 24. Canada Immune Globulin Intravenous Sales Growth Rate (2015-2020) (MT) Figure 25. Canada Immune Globulin Intravenous Revenue Growth Rate (2015-2020) (US$ Million) Figure 26. Europe Immune Globulin Intravenous Sales Market Share by Country in 2019 Figure 27. Europe Immune Globulin Intravenous Revenue Market Share by Country in 2019 Figure 28. Germany Immune Globulin Intravenous Sales Growth Rate (2015-2020) (MT) Figure 29. Germany Immune Globulin Intravenous Revenue Growth Rate (2015-2020) (US$ Million) Figure 30. France Immune Globulin Intravenous Sales Growth Rate (2015-2020) (MT) Figure 31. France Immune Globulin Intravenous Revenue Growth Rate (2015-2020) (US$ Million) Figure 32. U.K. Immune Globulin Intravenous Sales Growth Rate (2015-2020) (MT) Figure 33. U.K. Immune Globulin Intravenous Revenue Growth Rate (2015-2020) (US$ Million) Figure 34. Italy Immune Globulin Intravenous Sales Growth Rate (2015-2020) (MT) Figure 35. Italy Immune Globulin Intravenous Revenue Growth Rate (2015-2020) (US$ Million) Figure 36. Russia Immune Globulin Intravenous Sales Growth Rate (2015-2020) (MT) Figure 37. Russia Immune Globulin Intravenous Revenue Growth Rate (2015-2020) (US$ Million) Figure 38. Asia Pacific Immune Globulin Intravenous Sales Market Share by Region in 2019 Figure 39. Asia Pacific Immune Globulin Intravenous Revenue Market Share by Region in 2019 Figure 40. China Immune Globulin Intravenous Sales Growth Rate (2015-2020) (MT) Figure 41. China Immune Globulin Intravenous Revenue Growth Rate (2015-2020) (US$ Million) Figure 42. Japan Immune Globulin Intravenous Sales Growth Rate (2015-2020) (MT) Figure 43. Japan Immune Globulin Intravenous Revenue Growth Rate (2015-2020) (US$ Million) Figure 44. South Korea Immune Globulin Intravenous Sales Growth Rate (2015-2020) (MT) Figure 45. South Korea Immune Globulin Intravenous Revenue Growth Rate (2015-2020) (US$ Million) Figure 46. India Immune Globulin Intravenous Sales Growth Rate (2015-2020) (MT) Figure 47. India Immune Globulin Intravenous Revenue Growth Rate (2015-2020) (US$ Million) Figure 48. Australia Immune Globulin Intravenous Sales Growth Rate (2015-2020) (MT) Figure 49. Australia Immune Globulin Intravenous Revenue Growth Rate (2015-2020) (US$ Million) Figure 50. Taiwan Immune Globulin Intravenous Sales Growth Rate (2015-2020) (MT) Figure 51. Taiwan Immune Globulin Intravenous Revenue Growth Rate (2015-2020) (US$ Million) Figure 52. Indonesia Immune Globulin Intravenous Sales Growth Rate (2015-2020) (MT) Figure 53. Indonesia Immune Globulin Intravenous Revenue Growth Rate (2015-2020) (US$ Million) Figure 54. Thailand Immune Globulin Intravenous Sales Growth Rate (2015-2020) (MT) Figure 55. Thailand Immune Globulin Intravenous Revenue Growth Rate (2015-2020) (US$ Million) Figure 56. Malaysia Immune Globulin Intravenous Sales Growth Rate (2015-2020) (MT) Figure 57. Malaysia Immune Globulin Intravenous Revenue Growth Rate (2015-2020) (US$ Million) Figure 58. Philippines Immune Globulin Intravenous Sales Growth Rate (2015-2020) (MT) Figure 59. Philippines Immune Globulin Intravenous Revenue Growth Rate (2015-2020) (US$ Million) Figure 60. Vietnam Immune Globulin Intravenous Sales Growth Rate (2015-2020) (MT) Figure 61. Vietnam Immune Globulin Intravenous Revenue Growth Rate (2015-2020) (US$ Million) Figure 62. Latin America Immune Globulin Intravenous Sales Market Share by Country in 2019 Figure 63. Latin America Immune Globulin Intravenous Revenue Market Share by Country in 2019 Figure 64. Mexico Immune Globulin Intravenous Sales Growth Rate (2015-2020) (MT) Figure 65. Mexico Immune Globulin Intravenous Revenue Growth Rate (2015-2020) (US$ Million) Figure 66. Brazil Immune Globulin Intravenous Sales Growth Rate (2015-2020) (MT) Figure 67. Brazil Immune Globulin Intravenous Revenue Growth Rate (2015-2020) (US$ Million) Figure 68. Argentina Immune Globulin Intravenous Sales Growth Rate (2015-2020) (MT) Figure 69. Argentina Immune Globulin Intravenous Revenue Growth Rate (2015-2020) (US$ Million) Figure 70. Middle East and Africa Immune Globulin Intravenous Sales Market Share by Country in 2019 Figure 71. Middle East and Africa Immune Globulin Intravenous Revenue Market Share by Country in 2019 Figure 72. Turkey Immune Globulin Intravenous Sales Growth Rate (2015-2020) (MT) Figure 73. Turkey Immune Globulin Intravenous Revenue Growth Rate (2015-2020) (US$ Million) Figure 74. Saudi Arabia Immune Globulin Intravenous Sales Growth Rate (2015-2020) (MT) Figure 75. Saudi Arabia Immune Globulin Intravenous Revenue Growth Rate (2015-2020) (US$ Million) Figure 76. U.A.E Immune Globulin Intravenous Sales Growth Rate (2015-2020) (MT) Figure 77. U.A.E Immune Globulin Intravenous Revenue Growth Rate (2015-2020) (US$ Million) Figure 78. Sales Market Share of Immune Globulin Intravenous by Type (2015-2020) Figure 79. Sales Market Share of Immune Globulin Intravenous by Type in 2019 Figure 80. Revenue Share of Immune Globulin Intravenous by Type (2015-2020) Figure 81. Revenue Market Share of Immune Globulin Intravenous by Type in 2019 Figure 82. Global Immune Globulin Intravenous Sales Growth by Type (2015-2020) (MT) Figure 83. Global Immune Globulin Intravenous Sales Market Share by Application (2015-2020) Figure 84. Global Immune Globulin Intravenous Sales Market Share by Application in 2019 Figure 85. Global Revenue Share of Immune Globulin Intravenous by Application (2015-2020) Figure 86. Global Revenue Share of Immune Globulin Intravenous by Application in 2020 Figure 87. Baxter Total Revenue (US$ Million): 2019 Compared with 2018 Figure 88. Grifols Total Revenue (US$ Million): 2019 Compared with 2018 Figure 89. CSL Total Revenue (US$ Million): 2019 Compared with 2018 Figure 90. Octapharma Total Revenue (US$ Million): 2019 Compared with 2018 Figure 91. Biotest Total Revenue (US$ Million): 2019 Compared with 2018 Figure 92. Kedrion Total Revenue (US$ Million): 2019 Compared with 2018 Figure 93. Hualan Bio Total Revenue (US$ Million): 2019 Compared with 2018 Figure 94. CNBG Total Revenue (US$ Million): 2019 Compared with 2018 Figure 95. Shanghai RAAS Total Revenue (US$ Million): 2019 Compared with 2018 Figure 96. CBPO Total Revenue (US$ Million): 2019 Compared with 2018 Figure 97. LFB Group Total Revenue (US$ Million): 2019 Compared with 2018 Figure 98. BPL Total Revenue (US$ Million): 2019 Compared with 2018 Figure 99. Sichuan Yuanda Shuyang Total Revenue (US$ Million): 2019 Compared with 2018 Figure 100. Price Trend of Key Raw Materials Figure 101. Manufacturing Cost Structure of Immune Globulin Intravenous Figure 102. Manufacturing Process Analysis of Immune Globulin Intravenous Figure 103. Immune Globulin Intravenous Industrial Chain Analysis Figure 104. Channels of Distribution Figure 105. Distributors Profiles Figure 106. Porter's Five Forces Analysis Figure 107. North America Immune Globulin Intravenous Sales (MT) and Growth Rate Forecast (2021-2026) Figure 108. North America Immune Globulin Intravenous Revenue (Million US$) and Growth Rate Forecast (2021-2026) Figure 109. Europe Immune Globulin Intravenous Sales (MT) and Growth Rate Forecast (2021-2026) Figure 110. Europe Immune Globulin Intravenous Revenue (Million US$) and Growth Rate Forecast (2021-2026) Figure 111. Latin America Immune Globulin Intravenous Sales (MT) and Growth Rate Forecast (2021-2026) Figure 112. Latin America Immune Globulin Intravenous Revenue (Million US$) and Growth Rate Forecast (2021-2026) Figure 113. Middle East and Africa Immune Globulin Intravenous Sales (MT) and Growth Rate Forecast (2021-2026) Figure 114. Middle East and Africa Immune Globulin Intravenous Revenue (Million US$) and Growth Rate Forecast (2021-2026) Figure 115. Asia Pacific Immune Globulin Intravenous Sales (MT) and Growth Rate Forecast (2021-2026) Figure 116. Asia Pacific Immune Globulin Intravenous Revenue (Million US$) and Growth Rate Forecast (2021-2026) Figure 117. Bottom-up and Top-down Approaches for This Report Figure 118. Data Triangulation Figure 119. Key Executives Interviewed

This research study involved the extensive usage of both primary and secondary data sources.  The research process involved the study of various factors affecting the industry, including the government policy, market environment, competitive landscape, historical data, present trends in the market, technological innovation, upcoming technologies and the technical progress in related industry, and market risks, opportunities, market barriers and challenges. Top-down and bottom-up approaches are used to validate the global market size market and estimate the market size for manufacturers, regions segments, product segments and applications (end users). All possible factors that influence the markets included in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data. The market size for top-level markets and sub-segments is normalized, and the effect of inflation, economic downturns, and regulatory & policy changes or other factors are not accounted for in the market forecast. This data is combined and added with detailed inputs and analysis from QYResearch and presented in this report.
 

After complete market engineering with calculations for market statistics; market size estimations; market forecasting; market breakdown; and data triangulation, extensive primary research was conducted to gather information and verify and validate the critical numbers arrived at. In the complete market engineering process, both top-down and bottom-up approaches were extensively used, along with several data triangulation methods, to perform market estimation and market forecasting for the overall market segments and sub segments listed in this report. Extensive qualitative and further quantitative analysis is also done from all the numbers arrived at in the complete market engineering process to list key information throughout the report.
 

Secondary Sources occupies Approximately 25% of Sources, such as press releases, annual reports, Non-Profit organizations, industry associations, governmental agencies and customs data, and so on; This research study involved the usage of widespread secondary sources; directories; databases such as Bloomberg Business, Wind Info, Hoovers, Factiva (Dow Jones & Company), TRADING ECONOMICS, and avention; Investing News Network; statista; Federal Reserve Economic Data; annual reports; BIS Statistics; ICIS; company house documents; CAS(American Chemical Society); investor presentations; and SEC filings of companies. Secondary research was used to identify and collect information useful for the extensive, technical, market-oriented, and commercial study of the Light Aircraft market. It was also used to obtain important information about the top players, market classification and segmentation according to industry trends to the bottom-most level, and key developments related to market and technology perspectives.
 

In the primary research process, various sources from both the supply and demand sides were interviewed to obtain qualitative and quantitative information for this report. The primary sources from the supply side include product manufacturers (and their competitors), opinion leaders, industry experts, research institutions, distributors, dealer and traders, as well as the raw materials suppliers and producers etc.
 

The primary sources from the demand side include industry experts such as business leaders, marketing and sales directors, technology and innovation directors, supply chain executive, end users (product buyers), and related key executives from various key companies and organizations operating in the global market.
 

Primary research was conducted to identify segmentation types, product price range, product applications, key players, raw materials supply and the downstream demand, industry status and outlook, and key market dynamics such as risks, influence factors, opportunities, market barriers, industry trends, and key player strategies.
 

New Pharmaceuticals and Healthcare Reports

Internal Neuromodulation Market Forecast 2025 | Global Report

Rising number of patients suffering from neurological disorders such as Parkinson’s, essential tremor, and primary dystonia is fueling the demand for internal neuromodulation procedures. Chronic back and leg pain associated with PVD (peripheral...

Gastrointestinal Cancer Treatment Market Size 2020-2025 | Growth Forecasts

As per credible projections, gastrointestinal cancer treatment industry is expected to register strong CAGR over 2019-2025. Rising adoption of unhealthy eating habits and increasing consumption of tobacco and alcohol have increased the pervasiveness ...

Topotecan Hydrochloride Market Trends and Research Insights by 2025

As per credible estimates, global topotecan hydrochloride market is poised to acquire commendable gains by the year 2025. Rising adoption of unhealthy and sedentary lifestyle has increased the pervasiveness of small cell lung cancer, ovarian cancer, ...

Flu Vaccine Market Share 2020-2025 | Global Industry Report

As per trusted estimates, global flu vaccine market will record substantial growth during 2020-2025. Increasing government initiatives to ensure the safety of the populace, minimal side-effects associated with influenza vaccines, improving efficacy o...

Healthcare Linen Market Size - Industry Trends Report 2025

According to reliable projections, global healthcare linen market is projected to record considerable growth during 2020-2025. Rising prevalence of various diseases including cardiovascular diseases, cancer, and arthritis along with increasing cases ...

Other Reports by QY Research

Global Test Tubes Market Research Report 2020

Global Test Tubes Market: Drivers and Restrains The research report has incorporated the analysis of different factors that augment the market’s growth. It constitutes trends, restraints, and drivers that transform the market in either a positive ...

Global Stainless Steel Products Market Research Report 2020

The global Stainless Steel Products market is valued at US$ xx million in 2020 is expected to reach US$ xx million by the end of 2026, growing at a CAGR of xx% during 2021-2026. This report focuses on Stainless Steel Products volume and value at the...

Global LED Backlight Source Market Research Report 2020

Global LED Backlight Source Market: Drivers and Restrains The research report has incorporated the analysis of different factors that augment the market’s growth. It constitutes trends, restraints, and drivers that transform the market in either a...

Global Hay Balers Market Research Report 2020

Global Hay Balers Market: Drivers and Restrains The research report has incorporated the analysis of different factors that augment the market’s growth. It constitutes trends, restraints, and drivers that transform the market in either a positive ...

Global Hand Chain Hoist Market Research Report 2020

Global Hand Chain Hoist Market: Drivers and Restrains The research report has incorporated the analysis of different factors that augment the market’s growth. It constitutes trends, restraints, and drivers that transform the market in either a pos...

Publisher: QY Research